Anti-human immunodeficiency virus 1 (HIV-1) activities of 3-deazaadenosine analogs: increased potency against 3'-azido-3'-deoxythymidine-resistant HIV-1 strains - Wikidata - wikimedia - TriplyDB

Anti-human immunodeficiency virus 1 (HIV-1) activities of 3-deazaadenosine analogs: increased potency against 3'-azido-3'-deoxythymidine-resistant HIV-1 strains

Anti-human immunodeficiency virus 1 (HIV-1) activities of 3-deazaadenosine analogs: increased potency against 3'-azido-3'-deoxythymidine-resistant HIV-1 strains

http://www.wikidata.org/entity/Q28368280

about

Molecular characterization of Plasmodium falciparum S-adenosylmethionine synthetase Drug-Based Lead Discovery: The Novel Ablative Antiretroviral Profile of Deferiprone in HIV-1-Infected Cells and in HIV-Infected Treatment-Naive Subjects of a Double-Blind, Placebo-Controlled, Randomized Exploratory Trial Human immunodeficiency virus gene regulation as a target for antiviral chemotherapy.Determinants of sensitivity to DZNep induced apoptosis in multiple myeloma cells.Trimethylguanosine capping selectively promotes expression of Rev-dependent HIV-1 RNAs.Synthesis of a 6-methyl-7-deaza analogue of adenosine that potently inhibits replication of polio and dengue viruses Identification and pharmacological inactivation of the MYCN gene network as a therapeutic strategy for neuroblastic tumor cells Inhibition of histone lysine methylation enhances cancer-testis antigen expression in lung cancer cells: implications for adoptive immunotherapy of cancer In search of a selective antiviral chemotherapy.Suppression of EZH2 Prevents the Shift of Osteoporotic MSC Fate to Adipocyte and Enhances Bone Formation During Osteoporosis Putting an 'End' to HIV mRNAs: capping and polyadenylation as potential therapeutic targets.Viral Epitranscriptomics.Emerging role of SETDB1 as a therapeutic target.3-deazaadenosine, a S-adenosylhomocysteine hydrolase inhibitor, has dual effects on NF-kappaB regulation. Inhibition of NF-kappaB transcriptional activity and promotion of IkappaBalpha degradation.Induction of the Intrinsic Apoptotic Pathway by 3-Deazaadenosine Is Mediated by BAX Activation in HL-60 Cells.John Montgomery's legacy: carbocyclic adenosine analogues as SAH hydrolase inhibitors with broad-spectrum antiviral activity.Regulatory Role of N6 -methyladenosine (m6 A) Methylation in RNA Processing and Human Diseases.Impact of DNA and RNA Methylation on Radiobiology and Cancer Progression.

P2860

Q27973445-F8F5B9DF-0D57-44A0-BA94-D80D9338EBA6 Q28552171-2974221D-FB8B-4493-98B7-A4EC9195AA29 Q33541775-0A98CA4F-9E51-48ED-A4E0-23AC6C31A4D5 Q33948015-13CA3D37-1C9C-4755-ABD4-5BE738BC9AA0 Q34093156-52BF66E5-BE3A-4D1D-AE8C-E4D63065A6DA Q34144913-6EBA4141-E970-46D6-90AD-5AFFA35F6E10 Q35002896-4758707D-2031-43C0-9729-1C5942C35B7B Q35050623-BE1288FD-96F0-4245-9C03-FC103A5A1547 Q35375912-B48AFF7F-C66B-4209-B26E-0F4745965061 Q36756829-0A8AAD73-8E50-4006-BF4C-EFCDB1D2437D Q38170575-2C4A1B85-13CA-4E0C-9EBC-A38AB8BE1DE4 Q38934931-5DE17A2A-34F0-486A-A118-B90CF2C3CE76 Q39079803-A956F5F0-6DA8-4211-B9F0-3A38854F32B6 Q40945823-985BD119-D080-46A4-ABD0-1471C0233A22 Q41976710-0B6FB687-CC23-414C-BA67-F8869F9B4B12 Q44091038-1BF085C7-35A9-46AB-806C-914166FC9209 Q48168793-BF094201-3AB1-4B6C-B37A-E5B8543B935D Q50033803-BB45CE9F-76FC-4233-BAC2-26669D4DE0DC

P2860

Anti-human immunodeficiency virus 1 (HIV-1) activities of 3-deazaadenosine analogs: increased potency against 3'-azido-3'-deoxythymidine-resistant HIV-1 strains

http://www.wikidata.org/entity/Q28368280

description

1995 nî lūn-bûn

@nan

1995 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

1995 թվականի հունվարին հրատարակված գիտական հոդված

@hy

1995年の論文

@ja

1995年論文

@yue

1995年論文

@zh-hant

1995年論文

@zh-hk

1995年論文

@zh-mo

1995年論文

@zh-tw

1995年论文

@wuu

name

Anti-human immunodeficiency vi ...... midine-resistant HIV-1 strains

@ast

Anti-human immunodeficiency vi ...... midine-resistant HIV-1 strains

@en

Anti-human immunodeficiency vi ...... midine-resistant HIV-1 strains

@nl

type

label

Anti-human immunodeficiency vi ...... midine-resistant HIV-1 strains

@ast

Anti-human immunodeficiency vi ...... midine-resistant HIV-1 strains

@en

Anti-human immunodeficiency vi ...... midine-resistant HIV-1 strains

@nl

prefLabel

Anti-human immunodeficiency vi ...... midine-resistant HIV-1 strains

@ast

Anti-human immunodeficiency vi ...... midine-resistant HIV-1 strains

@en

Anti-human immunodeficiency vi ...... midine-resistant HIV-1 strains

@nl

P1433

Q28368280-ABB0A342-A680-4B75-8FA4-292B0813DF32

P1476

Q28368280-9DD9763D-281A-4E30-B1EF-865AB415D9F1

P2093

Q28368280-0FD5B5C9-827F-4A38-B1D4-B4F0A12B5BE5

Q28368280-4C5FD040-01A2-484C-AB40-066BF7B62B50

Q28368280-4DF3C031-D319-4374-B9DE-9D9377EE7207

Q28368280-672D98DA-EF7A-4076-86E0-9B690E914D9E

Q28368280-94E4C6F9-EB59-4316-9D56-FA56EAF2803D

Q28368280-A4484193-4B3F-408E-A8EB-A410A10AEBCB

Q28368280-C0B41662-849F-403D-A5F7-51E49FD1C00D

Q28368280-F172FDFE-B144-4556-98AE-83AC24FBAC48

Q28368280-FC341824-6716-401B-9748-CD6250AF173F

P2860

Q28368280-1C8B750D-242D-4938-BB0B-AC9EB835CC5C

Q28368280-1E35212A-D669-438D-BD12-B9992F4383AC

Q28368280-306BD5B5-9BE6-4FC1-9BF9-9D6CEA57396C

Q28368280-373EC385-FE9E-4064-8CDC-E343773CE894

Q28368280-37F950F5-D039-42B5-865B-C15B7F1AD9BF

Q28368280-386C3A8F-5A0E-4505-A14F-79D585896CE9

Q28368280-473B8E4F-73FE-4CD0-ACDC-0D56B6D0A450

Q28368280-503B6001-2A05-43B7-A7CF-3E44CA32F777

Q28368280-509C0B60-3073-42C8-ABCE-E76FFCA2A7E8

Q28368280-540D1764-7630-41FF-BBC0-3CF897FD79E2

P304

Q28368280-6488FE28-92F2-4CA5-8E4A-4A995D17270E

P31

Q28368280-95610785-44EC-40B9-855A-651C28E7B2F5

P3181

Q28368280-40FF5830-2266-4A12-A6E9-493F0029F2F8

P356

Q28368280-92373C18-E268-4093-BA48-839792C9D0BD

P407

Q28368280-C61A4C83-5AB8-4FEB-A128-CDBC53B94004

P433

Q28368280-456E9DA2-78B1-4C7B-87FD-90101CBAB05F

P478

Q28368280-DEB6E16F-B73F-49EA-908E-CDDCCE0FDBBA

P50

Q28368280-98F64E4C-45BA-4BAF-85B8-065B5F0A56B1

P577

Q28368280-774EB5A9-C0BD-4C5B-AEAB-71AE2E7D5025

P5875

Q28368280-A0A4733E-B002-4432-A607-4BB3C3317D2E

P698

Q28368280-D5B9DCCB-12DA-4155-AC96-DAA2BB717F43

P932

Q28368280-DCA1AB96-B473-4DFE-969B-F8B05967F27D

P3181

P356

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Anti-human immunodeficiency vi ...... midine-resistant HIV-1 strains

@en

P2093

A D Wolfe

http://www.w3.org/2001/XMLSchema#string

B Joshi

http://www.w3.org/2001/XMLSchema#string

B P Doctor

http://www.w3.org/2001/XMLSchema#string

D L Mayers

http://www.w3.org/2001/XMLSchema#string

D S Burke

http://www.w3.org/2001/XMLSchema#string

G E Garcia

http://www.w3.org/2001/XMLSchema#string

I K Hewlett

http://www.w3.org/2001/XMLSchema#string

J S Estrada

http://www.w3.org/2001/XMLSchema#string

R K Gordon

http://www.w3.org/2001/XMLSchema#string

P2860

Human proto-oncogene c-jun encodes a DNA binding protein with structural and functional properties of transcription factor AP-1

Molecular targets for AIDS therapy

3-Deaza-adenosine and inhibition of HIV

HIV with reduced sensitivity to zidovudine (AZT) isolated during prolonged therapy

Synthesis of 3-deazaneplanocin A, a powerful inhibitor of S-adenosylhomocysteine hydrolase with potent and selective in vitro and in vivo antiviral activities

Standardized peripheral blood mononuclear cell culture assay for determination of drug susceptibilities of clinical human immunodeficiency virus type 1 isolates. The RV-43 Study Group, the AIDS Clinical Trials Group Virology Committee Resistance Wor

Tumor cell autocrine motility factor

Rapidly and slowly replicating human immunodeficiency virus type 1 isolates can be distinguished according to target-cell tropism in T-cell and monocyte cell lines.

Rational approaches to the design of antiviral agents based on S-adenosyl-L-homocysteine hydrolase as a molecular target.

Negative regulation of human immune deficiency virus replication in monocytes. Distinctions between restricted and latent expression in THP-1 cells.

P304

215-9

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

1563558

http://www.w3.org/2001/XMLSchema#string

P356

10.1073/PNAS.92.1.215

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

92

http://www.w3.org/2001/XMLSchema#string

P50

P577

1995-01-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

15382029

http://www.w3.org/2001/XMLSchema#string

P698

7816820

http://www.w3.org/2001/XMLSchema#string

P932

42848

http://www.w3.org/2001/XMLSchema#string